Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
An Observational Study of Childhood Food Allergy
This study is currently recruiting participants.
Verified by National Institute of Allergy and Infectious Diseases (NIAID), April 2007
Sponsors and Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Consortium of Food Allergy Research
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00356174
  Purpose

The purpose of this study is to observe the natural course of food allergy, including both the development of peanut allergy in infants at high risk for developing this allergy, and the resolution of both egg and cow's milk allergy.

The study will correlate biological markers and immunologic changes associated with the development of food allergy and the resolution of allergies to egg and cow's milk. It will also evaluate important genetic and environmental influences on these food allergies.


Condition
Food Hypersensitivity
Peanut Hypersensitivity
Egg Hypersensitivity
Milk Hypersensitivity

MedlinePlus related topics: Allergy Food Allergy
U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: A Prospective Cohort Study of Immune Mechanisms, Genetic Factors, and Clinical and Environmental Characteristics Associated With the Occurrence and Clinical Outcome of Peanut Allergy

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Estimated Enrollment: 650
Study Start Date: July 2006
Detailed Description:

This observational study will investigate the developmental immunology of peanut, egg, and milk allergy in a cohort of milk- or egg-allergic children who are at risk for peanut allergy. This strategy will help to delineate, compare, and contrast biological markers and immunologic changes associated with the development of peanut allergy and loss of egg and milk allergy, while simultaneously evaluating important clinical and environmental influences likely to account for the recent rise in the prevalence of these allergies. The hallmark of food-allergic disease is the production of food-specific IgE antibodies that represent an end result of a Th2 influenced immune response. Currently, there is only a limited understanding of the mechanisms involved in the developmental course of food allergies. To effectively prevent or reverse the progression of food allergy, immune interventions will be needed. Furthermore, it is likely that successful strategies will need to be directed to those persons at identifiable risk (e.g., who have biomarkers associated with development of peanut allergy).

This study duration is planned for 5 years. There will be at least 7 study visits; at each study visit, medical, allergy, and diet history will be noted. At study entry, stool samples will be collected from infants and dust samples will be taken from their homes to assess for endotoxin and allergens in the home environment. At selected visits, participants will undergo a physical exam, atopic dermatitis and asthma evaluations, and blood collection. Oral food challenges will also occur at some visits, as clinically indicated. Infants will receive standard of care advice for treatment of egg, milk, and peanut allergy for the duration of the study.

In addition to the infants enrolled in this study, their full siblings will be asked to join the study as either genetic or mechanistic study controls, or both; controls will undergo allergy history at study entry. Siblings participating in genetic testing will have DNA collected by cheek swab; siblings participating in the mechanistic studies will have blood collected.

  Eligibility

Ages Eligible for Study:   3 Months to 15 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Children with milk or egg allergy who are at risk for peanut allergy

Criteria

Inclusion Criteria for Children with Food Allergy:

  • Have completed atopic dermatitis evaluation
  • Clinical history of allergy to cow's milk or egg and positive skin prick test (3 mm or larger) to cow's milk or egg OR moderate to severe atopic dermatitis and a positive prick skin test to cow's milk or egg OR positive oral food challenge (prior to study entry) to either cow's milk or egg and a positive skin prick test to cow's milk or egg
  • Parent or guardian willing to provide informed consent
  • Peanut-specific IgE of 5 kIU/l or less at the time of enrollment (for 380 of 400 participants)
  • Peanut-specific IgE of greater than 5 kIU/l at the time of enrollment (for 60 of 400 participants)

Exclusion Criteria for Children with Food Allergy:

  • Chronic disease requiring therapy (e.g., heart disease, diabetes). Children with asthma, atopic dermatitis, or rhinitis are not excluded.
  • Current participation in an interventional clinical trial
  • Inability to discontinue antihistamines for routine tests
  • Children from families with one child already participating in the study
  • Confirmed or convincing evidence of peanut allergy

Inclusion Criteria for Siblings of Children with Food Allergy:

  • Full sibling of child enrolled in the study
  • Parent or guardian willing to provide informed consent/signed assent, if applicable

Exclusion Criteria for Siblings of Children with Food Allergy Participating in Mechanistic Study:

  • History of food allergy
  • History of asthma, atopic dermatitis, or allergic rhinitis
  • History of chronic anemia
  • Immune system disease or taking medication that impairs immune responses
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00356174

Locations
United States, Arkansas
University of Arkansas for Medical Sciences Recruiting
Little Rock, Arkansas, United States, 72205
Contact: Suzanne Carlisle, RN     501-364-3749     carlislesuzannak@uams.edu    
United States, Colorado
National Jewish Medical and Research Center Recruiting
Denver, Colorado, United States, 80206
Contact: Jill Slinkard     303-398-1618     slinkardj@njc.org    
United States, Maryland
Johns Hopkins University School of Medicine Recruiting
Baltimore, Maryland, United States, 21205
Contact: Kim Mudd, RN, MSN     410-502-1711     knudd2@jhmi.edu    
United States, New York
Mount Sinai School of Medicine Recruiting
New York, New York, United States, 10029
Contact: Sheila Walsh, RN     212-241-7566     sheila.walsh@mssm.edu    
United States, North Carolina
Duke University Medical Center Recruiting
Durham, North Carolina, United States, 27710
Contact: Jan Kamilaris     919-681-3529     janet.kamilaris@duke.edu    
Sponsors and Collaborators
Consortium of Food Allergy Research
Investigators
Principal Investigator: Scott Sicherer, MD Jaffe Food Allergy Institute, Mount Sinai School of Medicine
Principal Investigator: Hugh Sampson, MD Pediatric Allergy and Immunology, Mount Sinai School of Medicine
  More Information

Publications:
Responsible Party: DAIT/NIAID ( Associate Director, Clinical Research Program )
Study ID Numbers: DAIT COFAR2
Study First Received: July 21, 2006
Last Updated: January 14, 2009
ClinicalTrials.gov Identifier: NCT00356174  
Health Authority: United States: Federal Government

Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Food Allergy

Study placed in the following topic categories:
Food Hypersensitivity
Hypersensitivity
Milk Hypersensitivity
Peanut Hypersensitivity
Hypersensitivity, Immediate
Egg Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases

ClinicalTrials.gov processed this record on February 12, 2009